Pictet Asset Management Portfolio holdings
AUM
$98.3B
1-Year Return
21%
This Quarter Return
+2.75%
1 Year Return
+21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$87.3B
AUM Growth
-$4.6B
(-5%)
Cap. Flow
-$5.79B
Cap. Flow
% of AUM
-6.64%
Top 10 Holdings %
Top 10 Hldgs %
18.42%
Holding
2,054
New
81
Increased
677
Reduced
810
Closed
85
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$617M |
| 2 |
Salesforce
CRM
|
$214M |
| 3 |
Adobe
ADBE
|
$185M |
| 4 |
Veeva Systems
VEEV
|
$156M |
| 5 |
Constellation Energy
CEG
|
$140M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$950M |
| 2 |
NVIDIA
NVDA
|
$534M |
| 3 |
Microsoft
MSFT
|
$230M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$204M |
| 5 |
NXP Semiconductors
NXPI
|
$192M |
Sector Composition
| 1 | Technology | 33.21% |
| 2 | Industrials | 17.72% |
| 3 | Healthcare | 13.34% |
| 4 | Consumer Discretionary | 7.59% |
| 5 | Utilities | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
RingCentral
RNG
$2.76B
| $142M | 0.16% |
5,038,757
-169,908
| -3% | -$4.79M |
|
152
Weyerhaeuser
WY
$18.4B
| $142M | 0.16% |
4,993,675
-756,665
| -13% | -$21.5M |
|
153
Idexx Laboratories
IDXX
$51.2B
| $141M | 0.16% |
289,418
+5,293
| +2% | +$2.58M |
|
154
Vertiv
VRT
$48B
| $141M | 0.16% |
1,625,404
-661,904
| -29% | -$57.3M |
|
155
Qualcomm
QCOM
$172B
| $139M | 0.16% |
700,324
+19,406
| +3% | +$3.87M |
|
156
Datadog
DDOG
$46B
| $138M | 0.16% |
1,064,723
+421,756
| +66% | +$54.7M |
|
157
Otis Worldwide
OTIS
$33.9B
| $138M | 0.16% |
1,430,245
-105,650
| -7% | -$10.2M |
|
158
Johnson Controls International
JCI
$70.1B
| $137M | 0.16% |
2,066,922
-682,230
| -25% | -$45.4M |
|
159
BioMarin Pharmaceuticals
BMRN
$10.9B
| $137M | 0.16% |
1,663,163
-242,446
| -13% | -$20M |
|
160
AbbVie
ABBV
$376B
| $136M | 0.16% |
793,230
-63,786
| -7% | -$10.9M |
|
161
argenx
ARGX
$44.9B
| $133M | 0.15% |
308,176
-20,992
| -6% | -$9.03M |
|
162
Moderna
MRNA
$9.45B
| $132M | 0.15% |
1,114,162
-1,507,475
| -58% | -$179M |
|
163
Pinnacle West Capital
PNW
$10.7B
| $131M | 0.15% |
1,712,299
-94,180
| -5% | -$7.19M |
|
164
PepsiCo
PEP
$201B
| $131M | 0.15% |
792,562
-76,646
| -9% | -$12.6M |
|
165
Avantor
AVTR
$8.99B
| $128M | 0.15% |
6,026,227
+197,444
| +3% | +$4.19M |
|
166
Revvity
RVTY
$9.95B
| $123M | 0.14% |
1,171,619
-92,899
| -7% | -$9.74M |
|
167
Bank of America
BAC
$375B
| $123M | 0.14% |
3,081,990
-32,359
| -1% | -$1.29M |
|
168
Union Pacific
UNP
$132B
| $122M | 0.14% |
540,829
-347,431
| -39% | -$78.6M |
|
169
Dominion Energy
D
$50.2B
| $122M | 0.14% |
2,495,307
-242,200
| -9% | -$11.9M |
|
|
BPMC
170
DELISTED
Blueprint Medicines
BPMC
| $122M | 0.14% |
1,127,302
-737,236
| -40% | -$79.5M |
|
171
Elevance Health
ELV
$69.4B
| $120M | 0.14% |
221,866
+5,663
| +3% | +$3.07M |
|
172
Cisco
CSCO
$269B
| $120M | 0.14% |
2,528,817
-1,262,373
| -33% | -$60M |
|
173
Neurocrine Biosciences
NBIX
$13.9B
| $120M | 0.14% |
871,324
-210,125
| -19% | -$28.9M |
|
174
Baidu
BIDU
$33.8B
| $116M | 0.13% |
1,343,329
+12,601
| +0.9% | +$1.09M |
|
175
Ionis Pharmaceuticals
IONS
$9.46B
| $115M | 0.13% |
2,409,954
-1,329,803
| -36% | -$63.4M |
|